Adverse Effects | MAB+EBRT %(n=117) | MAB+EBRT+PPB %(n=203) | χ ² | P Value |
---|---|---|---|---|
Acute Urology Function | ||||
ABS Grade 0 | 12.82 | 5.42 | 5.447 | 0.020 |
ABS Grade 1 | 48.72 | 25.12 | 18.480 | 0.000 |
ABS Grade 2 | 20.51 | 31.53 | 4.516 | 0.034 |
ABS Grade 3 | 5.13 | 23.15 | 17.449 | 0.000 |
ABS Grade 4 | 12.82 | 14.78 | 0.235 | 0.628 |
Late Urology Function | ||||
Urgent/Incontinence | 1.71 | 1.48 | 0.026 | 0.872 |
Hesitancy/Retention | 1.71 | 3.45 | 0.821 | 0.365 |
Gross Hematuria | 4.27 | 6.4 | 0.635 | 0.426 |
Stricture | 0 | 0.49 | 0.578 | 0.447 |
Frequency/Nocturia | 15.38 | 25.12 | 4.162 | 0.041 |
Acute Gastrointestinal Function | ||||
RTOG Grade 0 | 90.6 | 88.67 | 0.291 | 0.590 |
RTOG Grade 1 | 5.13 | 5.91 | 0.086 | 0.769 |
RTOG Grade 2 | 3.42 | 3.45 | 0.000 | 1.000 |
RTOG Grade 3 | 0.85 | 1.97 | 0.601 | 0.438 |
RTOG Grade 4 | 0 | 0 | —— | —— |
Late Gastrointestinal Function | ||||
Diarrhoea | 21.37 | 13.3 | 3.549 | 0.060 |
Nausea/Vomiting | 7.69 | 4.93 | 1.017 | 0.313 |
Abdominal Pain | 4.27 | 3.94 | 0.021 | 0.885 |
Rectal Bleeding | 5.13 | 10.34 | 2.614 | 0.106 |
Intestinal Fistula | 0 | 0.49 | 0.578 | 0.447 |
Endocriology Function | ||||
Breast Pain | 69.23 | 63.05 | 1.250 | 0.264 |
Xerosis Cutis | 11.11 | 19.7 | 3.966 | 0.046 |
Hot Flush | 20.51 | 37.44 | 9.897 | 0.002 |
Sexual Dysfunction | 53.85 | 47.78 | 1.091 | 0.296 |
Other System Function | ||||
Liver Dysfunction | 5.13 | 8.37 | 1.172 | 0.279 |
Renal Dysfunction | 7.69 | 6.4 | 0.192 | 0.661 |
Angina Pectoris | 34.18 | 25.12 | 2.997 | 0.083 |
Heart Failure | 7.69 | 2.96 | 3.727 | 0.054 |
Dyspnea | 3.42 | 0.99 | 2.389 | 0.122 |
Anaemia(moderate/severe) | 16.24 | 16.75 | 0.014 | 0.906 |